Jeffrey W. Albers - Director at Kymera Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
KYMR on Nasdaq
All Insider Reports
All Insider Reports

Jeffrey W. Albers - trading volume in the past year for Kymera Therapeutics, Inc.

Holdings reported by Jeffrey W. Albers for Kymera Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $49.10 Aug 26, 2024 Direct
Stock Option (Right to Buy) 11.3K Aug 26, 2024 Direct Common Stock

Transactions reported by Jeffrey W. Albers for Kymera Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.